What's Behind Mylan's Mixed Q1 Results

You might say that Mylan (NASDAQ:MYL) is a company in waiting. At some point over the next few months, its merger with Pfizer's Upjohn will close. Mylan will be no more; a new company named Viatris will be created from the merger.